[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 10.65 (-3.88%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 10.65 (-3.88%)
Ocular Therapeutix (NASDAQ:OCUL) Beats Expectations in Strong Q2 CY2026

Ocular Therapeutix (NASDAQ:OCUL) Beats Expectations in Strong Q2 CY2026

OCUL : 10.65 (-3.88%)
Ocular Therapeutix: Q2 Earnings Snapshot

Ocular Therapeutix: Q2 Earnings Snapshot

OCUL : 10.65 (-3.88%)
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Ocular’s AXPAXLI TM wet AMD NDA submission on track for Q4 2026 following positive Type C Meeting with the U.S. FDA in May 2026 FDA Type C Meeting Minutes Formalize SOL-1 Trial with Confirmatory...

OCUL : 10.65 (-3.88%)
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

NEO : 16.66 (-1.88%)
AORT : 27.71 (-1.32%)
OCUL : 10.65 (-3.88%)
3 Russell 2000 Stocks That Concern Us

3 Russell 2000 Stocks That Concern Us

TFIN : 74.15 (-1.07%)
BKU : 46.33 (+0.10%)
OCUL : 10.65 (-3.88%)
Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

OCUL : 10.65 (-3.88%)
3 Cash-Burning Stocks with Open Questions

3 Cash-Burning Stocks with Open Questions

MSTR : 125.11 (+4.91%)
RDNT : 75.66 (-1.51%)
OCUL : 10.65 (-3.88%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 10.65 (-3.88%)

Barchart Exclusives

Ahead of CrowdStrike Earnings, Here's What Barchart Data Says Comes Next for CRWD Stock
CrowdStrike is set to report its fiscal Q2 earnings on August 26. Barchart’s data is largely bullish on CRWD shares heading into the quarterly release. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.